231 related articles for article (PubMed ID: 8977385)
1. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome.
Freeth JS; Ayling RM; Whatmore AJ; Towner P; Price DA; Norman MR; Clayton PE
Endocrinology; 1997 Jan; 138(1):55-61. PubMed ID: 8977385
[TBL] [Abstract][Full Text] [Related]
2. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
[TBL] [Abstract][Full Text] [Related]
3. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
4. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture.
Thissen JP; Verniers J
Endocrinology; 1997 Mar; 138(3):1078-84. PubMed ID: 9048612
[TBL] [Abstract][Full Text] [Related]
10. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome.
Meacham LR; Brown MR; Murphy TL; Keret R; Silbergeld A; Laron Z; Parks JS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1379-83. PubMed ID: 8077336
[TBL] [Abstract][Full Text] [Related]
12. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
13. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform.
Pantel J; Grulich-Henn J; Bettendorf M; Strasburger CJ; Heinrich U; Amselem S
J Clin Endocrinol Metab; 2003 Apr; 88(4):1705-10. PubMed ID: 12679461
[TBL] [Abstract][Full Text] [Related]
15. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
[TBL] [Abstract][Full Text] [Related]
16. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of inherited growth hormone resistance in childhood.
Amselem S; Sobrier ML; Dastot F; Duquesnoy P; Duriez B; Goossens M
Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):353-69. PubMed ID: 8853444
[TBL] [Abstract][Full Text] [Related]
18. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
Melián E; Velasco B; Barrios R; Sanchez-Franco F
Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
[TBL] [Abstract][Full Text] [Related]
20. The D152H mutation found in growth hormone insensitivity syndrome impairs expression and function of human growth hormone receptor but is silent in rat receptor.
Esposito N; Wojcik J; Chomilier J; Martini JF; Kelly PA; Finidori J; Postel-Vinay MC
J Mol Endocrinol; 1998 Aug; 21(1):61-72. PubMed ID: 9723864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]